146 related articles for article (PubMed ID: 2030600)
21. Monoclonal antibodies against human myelomonocytic cells: detection of certain lineage-specific antigens on CFU-GM progenitor cells.
Takaishi M; Fu SM
J Immunol; 1985 Aug; 135(2):1523-9. PubMed ID: 2409154
[TBL] [Abstract][Full Text] [Related]
22. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.
Civin CI; Strauss LC; Brovall C; Fackler MJ; Schwartz JF; Shaper JH
J Immunol; 1984 Jul; 133(1):157-65. PubMed ID: 6586833
[TBL] [Abstract][Full Text] [Related]
23. SFL 23.6: a monoclonal antibody reactive with CFU-E, erythroblasts, and erythrocytes.
Gupta AD; Samoszuk MK; Papayannopoulou T; Stamatoyannopoulos G
Blood; 1985 Sep; 66(3):522-6. PubMed ID: 4027378
[TBL] [Abstract][Full Text] [Related]
24. Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL).
Shellard JE; Leitch HA; Logan PM; McMaster WR; Levy JG
Exp Hematol; 1991 Feb; 19(2):136-42. PubMed ID: 1991495
[TBL] [Abstract][Full Text] [Related]
25. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia.
Freedman MH; Cohen A; Grunberger T; Bunin N; Luddy RE; Saunders EF; Shahidi N; Lau A; Estrov Z
Br J Haematol; 1992 Jan; 80(1):40-8. PubMed ID: 1311195
[TBL] [Abstract][Full Text] [Related]
26. Effect of specific anti-human leukaemia immunotoxins on the colony formation by human haematopoietic progenitors and by human leukaemia cells.
Tebbi CK; Chervinsky D; Seon BK
Clin Exp Immunol; 1985 Jun; 60(3):496-500. PubMed ID: 3874727
[TBL] [Abstract][Full Text] [Related]
27. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of monoclonal antibodies recognizing two distinct differentiation antigens (Pro-Im1, Pro-Im2) on early hematopoietic cells.
Peng R; Al-Katib A; Knowles DM; Lu L; Broxmeyer H; Tolidjian B; Chiao JW; Koziner B; Wang CY
Blood; 1984 Dec; 64(6):1169-78. PubMed ID: 6388662
[TBL] [Abstract][Full Text] [Related]
29. Surface antigens on normal and leukaemic human cells detected by monoclonal antibodies.
Morstyn G; Metcalf D; Burgess A; Fabre JW
Scand J Haematol; 1981 Jan; 26(1):19-30. PubMed ID: 6162194
[TBL] [Abstract][Full Text] [Related]
30. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.
Lindner I; Kharfan-Dabaja MA; Ayala E; Kolonias D; Carlson LM; Beazer-Barclay Y; Scherf U; Hnatyszyn JH; Lee KP
J Immunol; 2003 Aug; 171(4):1780-91. PubMed ID: 12902478
[TBL] [Abstract][Full Text] [Related]
31. [Blast crisis of chronic myelogenous leukemia with blasts expressing both immature B lymphocyte- and myelomonocyte-associated antigens and differentiating into basophils in vitro].
Utsunomiya Y; Iwamasa K; Yasukawa M; Tamai T; Shiosaka T; Bando S
Rinsho Ketsueki; 1990 Jul; 31(7):1017-21. PubMed ID: 2214182
[TBL] [Abstract][Full Text] [Related]
32. Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow.
Bühring HJ; Müller CA; Letarte M; Gougos A; Saalmüller A; van Agthoven AJ; Busch FW
Leukemia; 1991 Oct; 5(10):841-7. PubMed ID: 1961019
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors.
Andrews RG; Singer JW; Bernstein ID
Blood; 1986 Mar; 67(3):842-5. PubMed ID: 3947749
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies detecting antigenic determinants with restricted expression on erythroid cells: from the erythroid committed progenitor level to the mature erythroblast.
Yokochi T; Brice M; Rabinovitch PS; Papayannopoulou T; Stamatoyannopoulos G
Blood; 1984 Jun; 63(6):1376-84. PubMed ID: 6202344
[TBL] [Abstract][Full Text] [Related]
35. Modulation of cell kinetics and cell cycle status by treating CD34+ chronic myeloid leukaemia cells with p53 antisense phosphorothioate oligonucleotides.
Lanza F; Bi S; Moretti S; Castoldi G; Goldman JM
Br J Haematol; 1995 May; 90(1):8-14. PubMed ID: 7786800
[TBL] [Abstract][Full Text] [Related]
36. Antigenic characteristics of erythropoietin dependent and independent erythroid progenitors (BFU-E and CFU-E) in polycythaemia vera and idiopathic myelofibrosis defined by monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1988; 36(6):733-47. PubMed ID: 3254121
[TBL] [Abstract][Full Text] [Related]
37. Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa.
Miyazaki H; Inoue H; Yanagida M; Horie K; Mikayama T; Ohashi H; Nishikawa M; Suzuki T; Sudo T
Exp Hematol; 1992 Aug; 20(7):855-61. PubMed ID: 1628703
[TBL] [Abstract][Full Text] [Related]
38. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
[TBL] [Abstract][Full Text] [Related]
39. Potent antileukemic activity of the novel agents norsegoline and dibezine.
Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
[TBL] [Abstract][Full Text] [Related]
40. Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis.
Dickinson AM; Middleton SL; Latham J; Dunn J; Thomas L; Proctor SJ
Leukemia; 1995 Mar; 9(3):444-9. PubMed ID: 7533866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
